Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Status:
Not yet recruiting
Trial end date:
2029-03-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, open, single-dose, dose-increasing trial，to evaluate the safety
and efficacy of STSG-0002 injection in patients with chronic hepatitis B treated with oral
antiviral therapy(Long-term follow-up).